Vitiligo on Darker Skin

Symptoms, Awareness, and treatment

This article is part of Health Divide: Skin Conditions and Darker Skin, a destination in our Health Divide series.

Vitiligo is a condition that causes patches of the skin to lose their natural color. White or lightened patches form when melanocytes (pigment cells that give color to our skin, hair, and eyes) are mistakenly destroyed by the body's immune system.

While vitiligo affects people of all skin types, it tends to be more noticeable in people with darker skin tones, contributing to additional stigmatization and psychological stress in members of Black, Brown, and Indigenous communities.

This article provides an overview of vitiligo in darker skin tones and how to help patients with darker skin actively manage the condition.


Zoe Hansen / Verywell Health

Facts and Misconceptions

Misconceptions continue to fuel stigma around vitiligo, particularly for Black and Brown patients.

Vitiligo is not contagious or life-threatening, but it often has a significant impact on quality of life, prompting heightened stress, anxiety, and stigmatization in already-marginalized patients.

How It Affects Different Skin Types

Vitiligo can affect anyone, regardless of race, ethnicity, age, or gender.

Vitiligo's most noticeable symptom—loss of skin coloration—tends to be more apparent in people with darker skin tones due to the contrast between the white patches and the person's natural skin tone.

Vitiligo on darker skin

Zoe Hansen / Verywell

Melanocytes and Melanin

A person's skin color stems from a process that involves cells called melanocytes. Melanocytes produce melanin, a pigment that gives your skin, hair, and eyes their unique color.

In skin pigmentation disorders like vitiligo, these melanocytes become damaged and unable to produce enough melanin, resulting in white or lightened patches.

Although the color of your skin is determined by the balance of its melanin, all people have roughly the same number of melanocytes.

Geographical Prevalence

Experts estimate that vitiligo affects up to 1% of the world's population, though many cases may go unreported. In the United States, this percentage may vary slightly depending on the region, but more research is needed to better understand how geographical location may impact vitiligo development.

A 2022 study indicated that Latinx and Hispanic patients are more likely to be living with an undiagnosed case of vitiligo, which affects overall prevalence estimates.

Link to Other Skin Conditions

Despite misconceptions, vitiligo is not related to other skin conditions like skin cancer, albinism (group of inherited conditions leading to extremely light skin, hair, and eyes), or leprosy, also called Hansen's disease (a long-term bacterial infection that causes skin lesions and nerve damage).

While in theory it's possible to have more than one of these skin conditions at the same time, vitiligo isn't the underlying cause.

Vitiligo and Skin Cancer Protection

Even though unpigmented patches of skin are more likely to sunburn, some research suggests that vitiligo may actually protect against skin cancer, not lead to it. Further, having a darker skin tone may increase this protection factor. Other studies have found that vitiligo patients with darker skin tones were even less likely to develop skin cancer than lighter populations.


The appearance of skin conditions in darker skin tones has been severely lacking in medical education and public health materials. Instead, a vast majority of images and descriptions focus almost solely on what skin conditions look like on White skin.

Without adequate training for healthcare providers to recognize what vitiligo looks like in different skin tones, Black and Brown patients often face a delayed or incorrect diagnosis and ineffective treatment.


A primary symptom of vitiligo in all skin tones is white or lightened patches on the skin or in hair. These patches may look more prominent on people with darker skin tones due to the contrast between the depigmented patches and the person's natural skin color.

Vitiligo on a person's face around the eye and on the eyelid

Reproduced with permission from © DermNet New Zealand and © Dr. Lawrence Meyerson 2023.

Vitiligo typically appears in areas where sun exposure is frequent, such as the hands, feet, face, and arms, though it can appear anywhere on the body, including:

  • Mouth and eyes
  • Fingers and wrists
  • Armpits
  • Groin
  • Genitals
  • Inside your mouth

It's also important to point out that several other pigment disorders also affect skin appearance and might be confused with vitiligo, particularly in Black and Brown patients. These include:

  • Pityriasis alba: A white facial patch commonly seen in children
  • Tinea versicolor: A fungal skin infection that develops into patches of discolored skin
  • Albinism: A group of inherited skin disorders that result in little or no pigment in a person's skin, eyes, and hair
  • Cutaneous T-cell lymphoma: A form of skin cancer, which can cause white patches that look like vitiligo (though this is rare)


Vitiligo patches are commonly found on both sides of the body symmetrically, usually in places where there has been frequent sun exposure, friction, or trauma.

Experts have broken down the subgroups of vitiligo by location and pattern, as follows:

  • Generalized vitiligo, which is the most common, means patches can appear anywhere on the body and don't have a specific size.
  • Focal vitiligo involves one or just a few white patches on a small area.
  • Acrofacial vitiligo describes patches found mostly on the fingers, toes, and face.
  • Mucosal vitiligo involves patches that are found around the mucous membranes, like the mouth, nose, or genitals.
  • Universal vitiligo is rare but happens when widespread patches cover almost the entire body.

There’s also the rarer segmental vitiligo, in which white patches appear on only one segment of the skin, like one side of the body. This type of vitiligo tends to stop growing once the initial patch is established.

What Causes Pigmentation Loss in Vitiligo?

Vitiligo is generally considered an autoimmune disease although it's not entirely clear what triggers the immune system to mistakenly attack its own healthy skin pigment cells. Experts think a combination of factors, such as genetics, stress, skin damage, chemical exposure, and viruses, are likely to influence the development of vitiligo.

When to See a Healthcare Provider

Vitiligo is not an urgent medical emergency, but it's still a medical condition. It's not just a cosmetic issue.

If possible and accessible, it's wise to see a healthcare provider as soon as you notice skin changes because people with vitiligo have a greater chance of developing certain autoimmune conditions and getting severe sunburns.

Plus, if you choose to get vitiligo treatments, the chances for a better outcome are greater with an earlier diagnosis.

Physical Examination

During an appointment for vitiligo, a healthcare provider will likely ask about your medical history and symptoms before looking at your skin. This physical examination will be more thorough than the casual skin checks you may have done at home.

For example, you can expect your healthcare provider to:

  • Observe all areas of your skin closely to note where the depigmentation patches occur, whether they're symmetrical or random, and whether they're on primarily sun-exposed areas.
  • Potentially shine an ultraviolet (UV) light known as a Wood's lamp against the white or lightened areas of your skin since vitiligo patches turn fluorescent under the lamp's light

If more information is needed, a healthcare provider may order the following tests:

  • A skin biopsy, which involves removing a small portion of the affected skin tissue to check for melanocytes. If none is present, this likely indicates vitiligo
  •  Blood tests, such as a complete blood count (CBC) or antinuclear antibody test (ANA test), to evaluate your overall health and check for any underlying autoimmune disease
health divide vitiligo

Julie Bang / Verywell

Questions to Ask

Research shows that vitiligo patients—particularly those from Black and Brown communities—face barriers when seeking care and treatment. This includes receiving an accurate, timely diagnosis and access to recommended vitiligo treatments.

Open communication with a healthcare provider can lead to better health outcomes for you. For some patients, this communication may be more comfortable and effective when the healthcare provider shares the same racial or ethnic background. But if that's not possible, it's completely acceptable to ask a healthcare provider if they're experienced diagnosing and treating skin of color.

From there, feel encouraged to be upfront with any questions or requests you may have. Some suggestions include:

  • What tests are required for a vitiligo diagnosis?
  • What are my chances of developing an autoimmune condition or experiencing mental health issues related to vitiligo?
  • If my treatment plan isn't effective or affordable, will you be able to provide alternative options?
  • How often should I schedule follow-up visits, and will I be able to contact you between appointments if necessary?

Mental Health Resources

While it's completely normal to feel stressed, embarrassed, or frustrated about living with a chronic skin condition like vitiligo, your quality of life and mental health do not need to suffer. Connecting with resources and support systems that are striving to destigmatize Black and Latinx/Hispanic mental health services can be a first step. Consider checking out:

Possible Co-Occurring Conditions

In addition to skin pigmentation loss, vitiligo can cause other symptoms such as pain and itching. People with vitiligo are also more likely to face conditions such as:

  • Vision and hearing changes: Melanocytes in the eye and inner ear can be affected by vitiligo, leading to visions changes, abnormal tear production, and hearing loss.
  • Psychological complications: Vitiligo can greatly affect a person's quality of life and may lead to symptoms of anxiety, depression, and other mental health conditions. Studies show that the quality of life in Black and Latinx/Hispanic vitiligo patients may be significantly more affected.
  • Autoimmune and thyroid disease: People with vitiligo have a higher chance of also having conditions like inflammatory bowel disease (IBD)psoriasisrheumatoid arthritislupus, and type 1 diabetes. Recent research suggests there may be a higher prevalence of autoimmune disease and hypothyroidism (underactive thyroid) in Black patients with vitiligo.

How to Find the Right Healthcare Provider

Amid a lack of diversity in the medical profession, many healthcare providers are focused on becoming more familiar with diagnosing and treating skin of color. It's perfectly acceptable and encouraged to do a little research on a healthcare provider to gauge their knowledge and understanding of darker skin. The doctor database created by the Skin of Color Society is a helpful place to start.

Treatment Options

There's no cure for vitiligo, but there are many different treatment options that can help slow the progression of vitiligo or return some color to white patches. However, some people choose not to treat their vitiligo at all.

Common vitiligo treatment options include:

  • Topical corticosteroid creams to try to restore pigment
  • UV light therapy to help stop the spread of white patches
  • Camouflaging creams matched closely to the unaffected areas for a temporary cosmetic fix
  • Depigmentation creams to remove the remaining pigment in the skin
  • Surgery to graft pigmented skin onto white patches
  • Janus kinase (JAK) inhibitors such as Opzelura (ruxolitinib) cream to help restore pigment

Keep in mind that treatment plans for patients with darker skin may require different approaches or dosages than those used for patients with light skin. For example, using UV light therapy in patients with darker skin tones may require higher doses to get results.

Treatment Costs

When they're not covered by insurance companies, vitiligo treatments are significantly less accessible and affordable, particularly for patients from historically marginalized communities who already face barriers to seeking care. If a vitiligo treatment you're interested in trying isn't accessible to you, ask the healthcare provider or another trusted source about available resources and support.


Vitiligo is a skin condition that causes your skin to lose melanin (pigment) in some areas, resulting in white or lightened patches. Although vitiligo is usually more noticeable on darker skin tones, research shows that it affects people of all ethnicities similarly.

Barriers to equitable health care plus a lack of medical education around what vitiligo looks like in darker skin tones make getting an accurate diagnosis and accessing effective treatments much more challenging.

A Word From Verywell

Living with a skin condition like vitiligo can be stressful and upsetting at times. It can be even more challenging when you feel marginalized for having darker skin. Through organizations like the Skin of Color Society, resources are available to help you find healthcare providers that are comfortable treating skin of color. Getting an accurate diagnosis and adequate treatment can help you live well with vitiligo.

Frequently Asked Questions

  • Do insurance plans cover vitiligo treatment?

    It depends. Some insurance companies may classify certain vitiligo treatments as "cosmetic" rather than medically necessary. And, unfortunately, research confirms inequities in vitiligo coverage that disproportionately impact patients with darker skin. Know that there are possible options for free or low-cost health insurance if needed, and don't hesitate to check with a healthcare provider or other trusted source if you have questions about paying for a health service.

  • Is pigmentation loss from vitiligo permanent in people with darker skin?

    Although some people with darker skin can experience a sudden return of skin color without treatment, pigmentation loss is usually permanent for most vitiligo patients. Fortunately, several treatment options can effectively restore skin color or camouflage the appearance of light patches in darker skin tones.

  • Where can you find vitiligo specialists?

    If you have access to a healthcare provider, consider asking them for a referral to a dermatologist (doctor who specializes in hair, skin, and nail conditions) who can treat vitiligo. In addition, the Skin of Color Society provides a free database in which you can search for local healthcare providers who are committed to providing culturally competent care.

34 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Vitiligo.

  2. Williams DR. Stress and the mental health of populations of color: advancing our understanding of race-related stressorsJ Health Soc Behav. 2018;59(4):466-485. doi:10.1177/0022146518814251

  3. Grimes PE, Miller MM. Vitiligo: Patient stories, self-esteem, and the psychological burden of disease. Int J Womens Dermatol. 2018;4(1):32-37. doi:10.1016/j.ijwd.2017.11.005

  4.  American Osteopathic College of Dermatology. Vitiligo.

  5. MedlinePlus. MC1R gene.

  6. Nemours Foundation. Skin, hair, and nails.

  7. MedlinePlus. Vitiligo.

  8. Silverberg JI, Reja M, Silverberg NB. Regional variation of and association of US birthplace with vitiligo extent. JAMA Dermatol. 2014;150(12):1298-1305. doi:10.1001/jamadermatol.2014.899

  9. Vitiligo Research Foundation. About vitiligo.

  10. Gandhi K, Ezzedine K, Anastassopoulos KP, et al. Prevalence of vitiligo among adults in the United States. JAMA Dermatol. 2022;158(1):43-50. doi:10.1001/jamadermatol.2021.4724

  11. Wen Y, Wu X, Peng H, et al. Cancer risks in patients with vitiligo: a Mendelian randomization studyJ Cancer Res Clin Oncol. 2020;146(8):1933-1940. doi:10.1007/s00432-020-03245-3

  12. Nordlund JJ. Vitiligo: A review of some facts lesser known about depigmentation. Indian J Dermatol. 2011;56(2):180-189. doi:10.4103/0019-5154.80413

  13. Kim HS, Kim HJ, Hong ES, et al. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in KoreaBr J Dermatol. 2019;182(4):907-915. doi:10.1111/bjd.18247

  14. Alvarado SM, Feng H. Representation of dark skin images of common dermatologic conditions in educational resources: A cross-sectional analysisJ Am Acad Dermatol. 2020;84(5):1427-1431. doi:10.1016/j.jaad.2020.06.041

  15. Adelekun A, Onyekaba G, Lipoff JB. Skin color in dermatology textbooks: An updated evaluation and analysisJ Am Acad Dermatol. 2021;84(1):194–196. doi:10.1016/j.jaad.2020.04.084

  16. Perlman KL, Williams NM, Egbeto IA, Gao DX, Siddiquee N, Park JH. Skin of color lacks representation in medical student resources: A cross-sectional study. Int J Womens Dermatol. 2021;7(2):195-196. doi:10.1016/j.ijwd.2020.12.018

  17. National Health Service. Vitiligo.

  18. Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus ConferencePigment Cell & Melanoma Research. 2012;25(3):E1-E13. doi:10.1111/j.1755-148X.2012.00997.x

  19. Speeckaert R, Lambert J, Bulat V, Belpaire A, Speeckaert M, van Geel N. Autoimmunity in segmental vitiligoFront Immunol. 2020;11:568447. doi:10.3389/fimmu.2020.568447

  20. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Vitiligo.

  21. American Academy of Dermatology. Is vitiligo a medical condition?.

  22. Bae JM, Lee RW. 365-nm narrowband Wood’s lamp for vitiligo and hypopigmentation disordersJournal of the American Academy of Dermatology. 2020;83(4):e283-e284. doi:10.1016/j.jaad.2019.08.064

  23. Yang Q, Zhang G, Su M, et al. Vitiligo skin biomarkers associated with favorable therapeutic response. Front Immunol. 2021;12:613031. doi:10.3389/fimmu.2021.613031

  24. Rodríguez-Martín M, Sáez M, Merino de Paz N, et al. When are laboratory tests indicated in patients with vitiligo?Dermato-Endocrinology. 2012;4(1):53-57. doi:10.4161/derm.19200

  25. Chen T, Grau C, Suprun M, Silverberg NB. Vitiligo patients experience barriers in accessing care. Cutis. 2016;98(6):385-388.

  26. Shen MJ, Peterson EB, Costas-Muñiz R, et al. The effects of race and racial concordance on patient-physician communication: A systematic review of the literatureJ. Racial and Ethnic Health Disparities. 2018;5(1):117-140. doi:10.1007/s40615-017-0350-4

  27. Takeshita J, Wang S, Loren AW, et al. Association of racial/ethnic and gender concordance between patients and physicians with patient experience ratingsJAMA Netw Open. 2020;3(11):e2024583. doi:10.1001/jamanetworkopen.2020.24583

  28. Linthorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, van der Veen JP. The burden of vitiligo: patient characteristics associated with quality of lifeJ Am Acad Dermatol. 2009;61(3):411-420. doi:10.1016/j.jaad.2009.03.022

  29. Dégboé B, Atadokpèdé F, Saka B, et al. Vitiligo on black skin: epidemiological and clinical aspects in dermatology, Cotonou (Benin)Int J Dermatol. 2017; 56(1): 92-96. doi:10.1111/ijd.13366

  30. Hadi A, Wang JF, Uppal P, Penn LA, Elbuluk N. Comorbid diseases of vitiligo: A 10-year cross-sectional retrospective study of an urban US population. J Amer Acad Dermatol. 2020;82(3):628-633. doi:10.1016/j.jaad.2019.07.036.

  31. Johns Hopkins Medicine. Skin pigment disorders.

  32. Bae JM, Ju HJ, Lee RW, et al. Evaluation for skin cancer and precancerous in patients with vitiligo treated with long-term narrowband UV-B phototherapy. JAMA Dermatol. 2020;156(5):529-537. doi:10.1001/jamadermatol.2020.0218

  33. Blundell A, Moniyka Sachar, Gabel CK, Bercovitch LG. The scope of health insurance coverage of vitiligo treatments in the United States: Implications for health care outcomes and disparities in children of color. Pediatr Dermatologic. 2021;38(2):79-85. doi:10.1111/pde.14714

  34. Taneja N, Sreenivas V, Sahni K, Gupta V, Ramam M. A cross-sectional study of spontaneous depigmentation in vitiligo. Indian J Dermatologic Venereol Leprol. 2020;86(3):240-250. doi:10.4103/ijdvl.IJDVL_409_18

By Cristina Mutchler
Cristina Mutchler is an award-winning journalist with more than a decade of experience in national media, specializing in health and wellness content.